Website
https://www.cataliocapital.com
Industry
6630 Fund management
Business classification
Financials

VCID: 14394494
Profile

Corporate information


Registration country
Investment activity status
Active investor

Company type

Multi-strategy investment firm focused on breakthrough biomedical technology companies worldwide.

Investment preferences

Private equity

Investment criteria
Focus on biomedical technology companies developing next-generation drugs, devices and diagnostics, data, tools, and healthcare services and work closely with each portfolio company to build and grow the business from inception to exit.
Stage focus
Series A

Selected investments

Country Notes
Orpheris Inc
Clinical-stage neuroscience company leveraging a platform technology that enabling selective delivery of therapeutic agents across the blood barrier. 		United States N/A
Initial investment. Round participant. Exited